Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Jan Cerny"'
Autor:
Siddhartha Ganguly, Andrew Daly, Tracey A. O'Brien, Melhem Solh, Steven Z. Pavletic, Rammurti T. Kamble, Leslie Lehmann, Tao Wang, Takanori Teshima, Amer Beitinjaneh, Miguel Pérez, Mahmoud Aljurf, Mukta Arora, John L. Wagner, Medhat Askar, Marjolein van der Poel, Madan Jagasia, Rabi Hanna, Alvaro Urbano-Ispizua, Ravi Vij, Armin Rashidi, Taiga Nishihori, Catherine J. Lee, A. Samer Al-Homsi, Vijaya Raj Bhatt, Michael T. Hemmer, Roger Strair, Hannah Choe, Joseph Pidala, Jeffery J. Auletta, Hisham Abdel-Azim, Vaibhav Agrawal, Shahinaz M. Gadalla, Stefan O. Ciurea, S Spellman, Margaret L. MacMillan, Rodrigo Martino, Jean-Yves Cahn, Mitchell S. Cairo, Basem M. William, Rizwan Romee, Jean A. Yared, Navneet S. Majhail, Annie Im, Usama Gergis, Mohamed A. Kharfan-Dabaja, Richard F. Olsson, Sagar S. Patel, Baldeep Wirk, Peiman Hematti, Michael Byrne, Asad Bashey, Hemant S. Murthy, Betty K. Hamilton, Muna Qayed, Pooja Khandelwal, Robert Peter Gale, Saurabh Chhabra, Gerhard C. Hildebrandt, Jan Cerny, Sachiko Seo, Roger H. Herzig, Nosha Farhadfar, Deepesh Lad, Hélène Schoemans, Akshay Sharma, Tim Prestidge, Lazaros J. Lekakis, Daniel J. Weisdorf, Paul Castillo, Miguel-Angel Perales
Publikováno v:
Biol Blood Marrow Transplant
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Biology of Blood and Marrow Transplantation, 26(8), 1459-1468. Elsevier Science
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Biology of Blood and Marrow Transplantation, 26(8), 1459-1468. Elsevier Science
Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD). Given its increasing use, we sought to determine risk factors for GVH
Autor:
Ulrike Bacher, Wael Saber, Uday R. Popat, Amer Beitinjaneh, Richard Gopez Ancheta, Shahinaz M. Gadalla, Jean-Yves Cahn, Ying Liu, Michael R. Grunwald, Hillard M. Lazarus, Jeff Szer, Naeem Chaudhri, Hisham Abdel-Azim, Nasheed Hossain, Richard F. Olsson, Gerhard C. Hildebrandt, Melhem Solh, Ronald Sobecks, Jacob M. Rowe, Shahrukh K. Hashmi, Zhen-Huan Hu, Jack W. Hsu, Yoshihiro Inamoto, Aaron T. Gerds, Harry C. Schouten, Mohamed A. Kharfan-Dabaja, Muthalagu Ramanathan, Matt Kalaycio, Jane L. Liesveld, Jan Cerny, David S. Snyder, Zachariah DeFilipp, Taiga Nishihori, Mark B. Juckett, Celalettin Ustun, Andrew Daly, Ashish Bajel, Mahmoud Aljurf, Bipin N. Savani, Rammurti T. Kamble, Mehdi Hamadani, Kirk R. Schultz, Mark R. Litzow, Mary Lynn Savoie, Ran Reshef, Jean A. Yared, Siddhartha Ganguly, Robert Peter Gale, Sachiko Seo, Edwin P. Alyea
Publikováno v:
Biol Blood Marrow Transplant
Biology of Blood and Marrow Transplantation, 26(3), 472-479. Elsevier Science
Biology of Blood and Marrow Transplantation, 26(3), 472-479. Elsevier Science
It remains unknown whether the administration of tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 after allogeneic hematopoietic cell transplantation (HCT) is associated with improved outcomes for patients with chronic myelogenous leukemia (CML).
Autor:
Rammurti T. Kamble, Anita D'Souza, Leslie Lehmann, Kirk R. Schultz, Miguel Angel Diaz, Nandita Khera, Anita J. Kumar, Karen K. Ballen, Siddhartha Ganguly, Yachiyo Kuwatsuka, Wael Saber, Susana R. Marino, Sachiko Seo, Ruta Brazauskas, Baldeep Wirk, Shahrukh K. Hashmi, Christopher Bredeson, Yoshihiro Inamoto, Khalid Bo-Subait, Jean A. Yared, Gregory A. Hale, Navneet S. Majhail, Akshay Sharma, Harry C. Schouten, Saurabh Chhabra, Cesar O. Freytes, Jason Tay, Christopher E. Dandoy, Kehinde Adekola, Bronwen E. Shaw, Stefan O. Ciurea, David Gómez Almaguer, Hasan Hashem, Amir Steinberg, Hemant S. Murthy, Raquel M. Schears, Ayami Yoshimi, Linda J. Burns, David Szwajcer, David I. Marks, Tami John, Richard F. Olsson, Charles F. LeMaistre, William A. Wood, Jan Cerny, Susan K. Parsons, David Buchbinder, Usama Gergis, Nosha Farhadfar, Theresa Hahn, Mahmoud Aljurf, Hélène Schoemans, Sherif M. Badawy, Bipin N. Savani, Sara Beattie, Hillard M. Lazarus
Publikováno v:
Biol Blood Marrow Transplant
Biology of Blood and Marrow Transplantation, 26(3), 553-561. Elsevier Science
Biology of Blood and Marrow Transplantation, 26(3), 553-561. Elsevier Science
Follow-up is integral for hematopoietic cell transplantation (HCT) care to ensure surveillance and intervention for complications. We characterized the incidence of and predictors for being lost to follow-up. Two-year survivors of first allogeneic HC
Autor:
Hillard M. Lazarus, Minoo Battiwalla, Jean A. Yared, Baldeep Wirk, Robert Peter Gale, Ibrahim Ahmed, Marcelo C. Pasquini, Sachiko Seo, Bipin N. Savani, Leona Holmberg, Richard T. Maziarz, Gerhard C. Hildebrandt, Richard F. Olsson, Nelli Bejanyan, Shahinaz M. Gadalla, Mingwei Fei, Kehinde Adekola, Mahmoud Aljurf, Oscar B Lahoud, Jeffrey Auletta, Seth J. Rotz, Vaibhav Agrawal, Claudio G. Brunstein, Jan Cerny, Soyoung Kim, Shin Mineishi, Vikram Mathews, Harry C. Schouten, Siddhartha Ganguly, Cesar O. Freytes, Miguel-Angel Perales, Joseph S. Bubalo, Peiman Hematti, Maxim Norkin, Ran Reshef, Marcos de Lima, Taiga Nishihori, Stefan O. Ciurea, John Rogosheske, Heather Landau, Lynette Chee, Shahrukh K. Hashmi
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol 25, iss 3
Biology of Blood and Marrow Transplantation, 25(3), 480-487. Elsevier Science
Biology of Blood and Marrow Transplantation, 25(3), 480-487. Elsevier Science
Data are limited on whether to adjust high-dose chemotherapy before autologous hematopoietic cell transplant (autoHCT) in obese patients. This study explores the effects of dose adjustment on the outcomes of obese patients, defined as body mass index
Autor:
Ronald Sobecks, Brian T. Hill, Matthew D. Seftel, Richard F. Olsson, Zhen-Huan Hu, Mohamed A. Kharfan-Dabaja, Yoshihiro Inamoto, Kwang Woo Ahn, Amer Beitinjaneh, Martin S. Tallman, Matt Kalaycio, Sachiko Seo, Ayman Saad, Michael R. Grunwald, Richard T. Maziarz, Edwin P. Alyea, Mahmoud Aljurf, Jean-Yves Cahn, Jeff Szer, Nilanjan Ghosh, Tamila L. Kindwall-Keller, Siddhartha Ganguly, Uday R. Popat, Taiga Nishihori, Celalettin Ustun, Jan Cerny, Wael Saber, Peter H. Wiernik
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:581-586
Chronic lymphocytic leukemia (CLL) is a common hematologic malignancy with many highly effective therapies. Chemorefractory disease, often characterized by deletion of chromosome 17p, has historically been associated with very poor outcomes, leading
Autor:
Siddhartha Ganguly, Ran Reshef, Attaphol Pawarode, Wael Saber, Abhinav Deol, Taiga Nishihori, Thomas R. Klumpp, Selina M. Luger, William A. Wood, Richard F. Olsson, Maxim Norkin, Mahmoud Aljurf, Martin S. Tallman, Baldeep Wirk, Bruno C. Medeiros, Muthalagu Ramanathan, Minoo Batiwalla, Ayman Saad, Betul Oran, Mei-Jie Zhang, Rammurti T. Kamble, Mark R. Litzow, Jean-Yves Cahn, Olle Ringdén, Jane L. Liesveld, Mitchell S. Cairo, Michael A. Pulsipher, Jan Cerny, Geoffrey L. Uy, Marcelo C. Pasquini, Biju George, Edward A. Copelan, Daniel J. Weisdorf, Rodrigo Martino, Gregory A. Hale, Gorgun Akpek, Bipin N. Savani, Zhen-Huan Hu, Vikas Gupta, Waleska S. Pérez, Harry C. Schouten, Cesar O. Freytes, David I. Marks, Robert Peter Gale, Philippe Armand, Hillard M. Lazarus
Publikováno v:
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Biology of Blood and Marrow Transplantation, 22(2), 248-257. Elsevier Science
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Biology of Blood and Marrow Transplantation, 22(2), 248-257. Elsevier Science
The presence of monosomal karyotype (MK+) in acute myeloid leukemia (AML) is associated with dismal outcomes. We evaluated the impact of MK+ in AML (MK+AML, n = 240) and in myelodysplastic syndrome (MDS) (MK+MDS, n = 221) on hematopoietic cell transp
Autor:
Muthalagu Ramanathan, Rajneesh Nath, Sakiko Suzuki, Jan Cerny, Glen D. Raffel, Zeina Al-Mansour, Jonathan M. Gerber
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S213
Introduction Allo HCT is a curative option for many aggressive hematological malignancies that increase with age. HAPLO donors and UCB are alternative sources of hematopietic cells for patients lacking a matched sibling or unrelated donor. The choice
Autor:
Baldeep Wirk, Shahrukh K. Hashmi, Amer Beitinjaneh, Jean A. Yared, Sanghee Hong, Edward A. Copelan, Lori Muffly, Jeffery J. Auletta, Andrew Daly, Aleksandr Lazaryan, Miguel Angel Diaz, Betty K. Hamilton, Hillard M. Lazarus, Minoo Battiwalla, Xiaochun Zhu, Jean-Yves Cahn, Andrew S. Artz, Miguel-Angel Perales, Saurabh Chhabra, Richard F. Olsson, Maxim Norkin, Gerhard C. Hildebrandt, Mitchell Sabloff, Arnon Nagler, Peiman Hematti, Jan Cerny, Allistair Abraham, Rodrigo Martino Bufarull, Marcelo C. Pasquini, Siddhartha Ganguly, Taiga Nishihori, Selina M. Luger, Ajoy Dias, Robert Peter Gale, Armin Rashidi, Shin Mineishi, Leona Holmberg, Cesar O. Freytes, Natasha Kekre, Celalettin Ustun, Christopher Bredeson, Ann E. Woolfrey, Rizwan Romee, Kehinde Adekola, Tao Wang, Matthew L. Ulrickson, Ayman Saad, Sachiko Seo, Gregory A. Hale
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:S94-S95
Autor:
Rajneesh Nath, Muthalagu Ramanathan, Saranya Kodali, Eswar Tipirneni, Hongbo Yu, Zheng Zhou, Jan Cerny
Publikováno v:
Biology of Blood and Marrow Transplantation. 21(2)
Autor:
Glen D. Raffel, Lindsey Shanahan, Jan Cerny, Austin I. Kim, Neng Yu, Rajneesh Nath, Zheng Zhou, Zeina Al-Mansour, Muthalagu Ramanathan
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:S343-S344